The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials

BACKGROUND: Ascites is the most common complication of cirrhosis. It may lead to the consequence of poor prognosis and the deterioration of quality of life. Asopressin V2 receptor antagonists is a kind of vaptans, and it has been proved to be effective in hyponatremia patients. We conducted a meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Long, Xie, Feng, Lu, Jiongjiong, Ni, Qingqiang, Shi, Changying, Tang, Caixi, Yang, Jiamei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460759/
https://www.ncbi.nlm.nih.gov/pubmed/26054761
http://dx.doi.org/10.1186/s12876-015-0297-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460759/
https://www.ncbi.nlm.nih.gov/pubmed/26054761
http://dx.doi.org/10.1186/s12876-015-0297-z

Ejemplares similares